Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Betjes MGH, Kho MML, Litjens NHR, de Weerd AE, et al. Alemtuzumab as Second-Line Treatment for Late Antibody-Mediated Rejection of Transplanted Kidneys. Transplant Proc 2021;53:2206-2211.
PMID: 34376313


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016